DRIVIN G ROWTH - Dr. Reddy's

1986
Commenced: Operations
with one facility; currently
has four facilities
branded formulations
1987
Launched: Norilet, a
neuropsychiatry drug;
Dr. Reddy's first recognised
brand in India
The branded formulations
business has evolved from
a Indian market player to a
global organisation. Starting
with brands based on its own
formulations, it has grown
through brand and company
acquisitions, a valuable
product mix, distribution
strength, and therapeutic area
focus to become one of the
country’s largest players. The
1989
Launched: Enam, our first
Enalapril drug; currently
No. 2 in this segment in
India
figures: from Rs. 4.7 mn. in
1987 to Rs. 6,057 mn. in 2002.
In addition, alliances and joint
ventures have helped rapidly
grow its international
operations, which are key to
its move up the value chain.
Dr. Reddy’s branded
formulations are marketed in
countries across Russia, CIS,
Latin America, South Asia,
China and Africa.
1991
Launched: Omez, our
first Omeprozole drug;
currently No. 1 in this
segment in India